Literature DB >> 16178984

Circulating leptin and body composition in chronic obstructive pulmonary disease.

S Karakas1, F Karadag, A B Karul, O Gurgey, S Gurel, E Guney, O Cildag.   

Abstract

Nutritional depletion and weight loss are two features of chronic obstructive pulmonary disease (COPD), and the association between low body mass index (BMI) and poor prognosis in patients with COPD is a common clinical observation. Mechanisms of weight loss are still unclear in COPD. Excessive energy expenditure partly due to increased work of breathing was shown, but other mechanisms have been searched for. Leptin is a hormone secreted by adipocytes that plays an important role in energy homeostasis and regulates body weight through control of appetite and energy expenditure. The aim of this study was to evaluate the association of circulating leptin levels and measures of body composition in COPD patients. Thirty male COPD outpatients (mean age 66.3 +/- 8.4) and 20 controls (mean age 65.9 +/- 10.8) were included in the study. After standard spirometry and body composition measurements, serum leptin concentration was measured by ELISA assay. COPD patients were grouped according to BMI. Mean BMI was 19.01 +/- 2.26 kg/m2 in group 1 (COPD patients with low BMI), 26.85 +/- 4.51 in group 2 COPD (COPD patients with normal/high BMI) and 27.64 +/- 2.75 kg/m2 in healthy controls (group 3). Mean serum leptin concentration was 1.41 +/- 1.86 ng/ml in group 1, 2.60 +/- 1.38 ng/ml in group 2 and 2.82 +/- 1.46 ng/ml in group 3 (p = 0.002). Leptin correlated to not only BMI but also body weight, waist circumference, triceps and biceps skinfold thickness and body fat percent (p < 0.05 for all). Results of this study suggest that the cause of weight loss is not increased circulating leptin in COPD. Instead, leptin remains regulated in COPD and further decreased in patients with low BMI, probably as a compensatory mechanism to preserve body fat content, which should be evaluated in further studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16178984     DOI: 10.1111/j.1368-5031.2005.00567.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  7 in total

1.  Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.

Authors:  Fisun Karadag; Aslihan B Karul; Orhan Cildag; Mustafa Yilmaz; Hatice Ozcan
Journal:  Lung       Date:  2008-09-20       Impact factor: 2.584

Review 2.  Obesity, adipokines, and lung disease.

Authors:  Akshay Sood
Journal:  J Appl Physiol (1985)       Date:  2009-11-19

3.  Loss of phosphatase and tensin homolog (PTEN) induces leptin-mediated leptin gene expression: feed-forward loop operating in the lung.

Authors:  Ravi Ramesh Pathak; Aditya Grover; Prerna Malaney; Waise Quarni; Ashish Pandit; Diane Allen-Gipson; Vrushank Davé
Journal:  J Biol Chem       Date:  2013-08-20       Impact factor: 5.157

4.  Effects of Cigarette Smoke on Adipose and Skeletal Muscle Tissue: In Vivo and In Vitro Studies.

Authors:  Lei Wang; Lieke E J van Iersel; Charlotte E Pelgrim; Jingyi Lu; Ingrid van Ark; Thea Leusink-Muis; Harry R Gosker; Ramon C J Langen; Annemie M W J Schols; Josep M Argilés; Ardy van Helvoort; Aletta D Kraneveld; Johan Garssen; Paul A J Henricks; Gert Folkerts; Saskia Braber
Journal:  Cells       Date:  2022-09-16       Impact factor: 7.666

Review 5.  Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.

Authors:  Aibek E Mirrakhimov
Journal:  Cardiovasc Diabetol       Date:  2012-10-27       Impact factor: 9.951

Review 6.  Undernutrition in patients with COPD and its treatment.

Authors:  Masayuki Itoh; Takao Tsuji; Kenji Nemoto; Hiroyuki Nakamura; Kazutetsu Aoshiba
Journal:  Nutrients       Date:  2013-04-18       Impact factor: 5.717

7.  Effects of TNF-alpha and leptin on weight loss in patients with stable chronic obstructive pulmonary disease.

Authors:  Kyeong-Cheol Shin; Jin Hong Chung; Kwan Ho Lee
Journal:  Korean J Intern Med       Date:  2007-12       Impact factor: 3.165

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.